Johng Rhim

Johng Rhim


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2010 in Pathology International
Verified
Journal Article
Closed access
PDF file
BFBungo Furusato
Bungo Furusato
AMAhmed Mohamed
Ahmed Mohamed
MUMathias Uhlen
Mathias Uhlen
JRJohng Rhim
Johng Rhim

15 August 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Rofaida GaballaRofaida Gaballa
Rofaida Gaballa
HAHamdy Ebraheam Abouzeid Ali
Hamdy Ebraheam Abouzeid Ali
MMMohamed Mahmoud
Mohamed Mahmoud
JRJohng Rhim
Johng Rhim
HAHamed I. Ali
Hamed I. Ali
Zakaria Y. Abd ElmageedZakaria Y. Abd Elmageed
Zakaria Y. Abd Elmageed
Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.

22 October 2010 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
STShaniece Theodore
Shaniece Theodore
SSStarlette Sharp
Starlette Sharp
JZJianjun Zhou
Jianjun Zhou
TTTimothy Turner
Timothy Turner
HLHongzhen Li
Hongzhen Li
JRJohng Rhim
Johng Rhim
Research into molecular and genetic mechanisms underlying prostate carcinogenesis in high-risk African American men would be greatly advanced by in vitro models of African American prostate tumors representing primary tumors. However, the generation of immortalized primary African American prostate cancer cells that will accurately reflect the in situ characteristics of malignant epithelium is currently limited but is greatly needed. We have successfully established immortalized cell lines of a pair of non-malignant and malignant tumors derived from an African American prostate cancer patient with HPV-16E6E7 (RC-77N/E and RC-77T/E). RC-77N/E and RC-77T/E cells are currently growing well at passage 40. Both cells exhibit epithelial morphology and are androgen sensitive. The RC-77T/E cells produced tumors in SCID mice whereas the RC-77N/E cells produced no tumor in SCID mice. These cells expressed androgen-regulated prostate-specific homobox gene, NKX 3.1, epithelial cell specific cytokeratn 8, androgen receptor (AR), prostate specific antigen (PSA), and p16. Chromosome analysis showed that both cell lines are similar; near diploid human male (XY) with most chromosome counts in the 45-48 range. However, RC-77T/E cell line has new marker chromosomes: M1B=del/t(4;?)(q28;?), M5=16q+ in addition to those observed in the RC-77N/E cell line (M1=del(4)(q28q34)+hsr in some, M1A=t(4q;?),M2=der(9?),M2A=del(M2p-),M3=iso(?), M4=der(22?)). This is the first documented case of the establishment of pair of non-malignant and malignant tumors derived from an African American prostate cancer patient. These models will provide novel tools to study the molecular and genetic mechanisms of prostate carcinogenesis, especially for high-risk African American men.

30 April 2009
Verified
Book Chapter
Closed access
PDF file
BFBungo Furusato
Bungo Furusato
JRJohng Rhim
Johng Rhim

27 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
RMRania Makboul
Rania Makboul
IAIslam F. Abdelkawi
Islam F. Abdelkawi
DBDalia Badary
Dalia Badary
Mahmoud HusseinMahmoud Hussein
Mahmoud Hussein
JRJohng Rhim
Johng Rhim
Zakaria Y. Abd ElmageedZakaria Y. Abd Elmageed
Zakaria Y. Abd Elmageed
The histopathologic diagnosis of prostate cancer (PCa) from biopsies is a current challenge if double or triple staining is needed. Therefore, there is an urgent need for development of a new reliable biomarker to diagnose PCa patients. We aimed to explore and compare the expression of TMTC4 in PCa cells and tissue specimens and evaluate its sensitivity and specificity. The expression of TMTC4 in PCa and normal prostate epithelial cells was determined by real-time PCR and Western blot analyses. Immunohistochemical (IHC) staining of TMTC4 was performed on tissues collected from PCa and benign prostatic hyperplasia (BPH). Our results show a high expression of TMTC4 on mRNA and protein levels in PCa versus BPH1 and normal cells (p < 0.05). IHC results show strong cytoplasmic expressions in PCa cases (p < 0.001) as compared to BPH cases. The overall accuracy as measured by the AUC was 1.0 (p < 0.001). The sensitivity and specificity of the protein were 100% and 96.6%, respectively. Taken together, we report a high TMTC4 expression in PCa cells and tissues and its ability to differentiate between PCa and BPH with high sensitivity and specificity. This finding can be carried over to clinical practice after its confirmation by further studies.

11 October 2012
Verified
Book Chapter
Closed access
PDF file
JRJohng Rhim
Johng Rhim